Optiscan has been featured in the Sydney Morning Herald, The Age, and the Brisbane Times, regarding our recent telepathology platform announcement.

The articles emphasize the groundbreaking nature of Optiscan's telepathology platform, especially its capability to provide remote access for pathologists, allowing them to perform virtual biopsy assessments without the need for an actual biopsy.

"The company’s 'pen-like' microscope is extraordinarily powerful and capable of delivering a real-time cancer diagnosis without the need for painful biopsies. The development of the cloud-based platform will allow cancer experts to diagnose cancer remotely from anywhere in the world using Optiscan’s device."

Read the full articles here:

Sydney Morning Herald

The Age

Brisbane Times